These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
7/27/2017
7:00 AM ET
Press Release

Repligen to Report Second Quarter 2017 Financial Results

7/27/2017

WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report second quarter of 2017 financial results on Thursday, August 3, 2017...

 Continue Reading
6/27/2017
7:05 PM ET
Press Release

Repligen Corporation Prices Public Offering of Shares of Common Stock

6/27/2017

WALTHAM, Mass., June 27, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the pricing of an underwritten public offering of 2,807,017 shares of its common stock at a publi...

 Continue Reading
6/26/2017
5:12 PM ET
Press Release

Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock

6/26/2017

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that it has commenced an underwritten public offering of $100,000,000 in shares of its common sto...

 Continue Reading
6/23/2017
7:00 AM ET
Press Release

Repligen Corporation and Spectrum, Inc. to Join Forces

6/23/2017

- Adds to Repligen a leader in bioprocess filtration with expertise in hollow fiber technology- Strengthens flagship XCell™ ATF product line with an extensive filtration consumables portfolio- Diversi...

 Continue Reading
5/31/2017
7:30 AM ET
Press Release

Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference

5/31/2017

WALTHAM, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will pres...

 Continue Reading
Displaying 1 to 5 (of 199 releases)